CoChat
Sign Up
Cited by 134

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Biology of Aβ Amyloid in Alzheimer's Disease

Wisniewski, Thomas, Ghiso, Jorge, Frangione, Blas·1997·Neurobiology of Disease
DOI 10.1006/nbdi.1997.0147
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1006/nbdi.1997.0147

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 155

  1. Abraham, 1988, Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease, Cell, 52, 487, 10.1016/0092-8674(88)90462-X · DOI
  2. Behl, 1992, Vitamin E protects nerve cells from amyloid protein toxicity, Biochem. Biophys. Res. Commun., 186, 944, 10.1016/0006-291X(92)90837-B · DOI
  3. Biere, 1996, Amyloid β-peptide is transported on lipoproteins and albumin in human plasma, J. Biol. Chem., 271, 32916, 10.1074/jbc.271.51.32916 · DOI · Paper page
  4. Blacker, 1997, ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative, Neurology, 48, 139, 10.1212/WNL.48.1.139 · DOI · Paper page
  5. Borchelt, 1996, Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo, Neuron, 17, 1005, 10.1016/S0896-6273(00)80230-5 · DOI · Paper page
  6. Bouras, 1996, Presenilin-1 polymorphism and Alzheimer's disease, Lancet, 347, 1185, 10.1016/S0140-6736(96)90643-1 · DOI
  7. Busciglio, 1993, Generation of β-amyloid in the secretory pathway in neuronal and non-neuronal cells, Proc. Natl. Acad. Sci. USA, 90, 2092, 10.1073/pnas.90.5.2092 · DOI · Paper page
  8. Butterfield, 1994, Beta-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease, Biochem. Biophys. Res. Commun., 200, 710, 10.1006/bbrc.1994.1508 · DOI
  9. Castaño, 1995, Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease, J. Biol. Chem., 270, 17610, 10.1074/jbc.270.29.17610 · DOI
  10. Castaño, 1995, Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E, Biochem. J., 306, 599, 10.1042/bj3060599 · DOI · Paper page
  11. Castaño, 1996, The length of amyloid-β in hereditary cerebral hemorrhage with amyloidosis, Dutch type—Implications for the role of amyloid-β 1-42 in Alzheimer's disease, J. Biol. Chem., 271, 32185, 10.1074/jbc.271.50.32185 · DOI
  12. Choi-Miura, 1992, SP-40, 40 is a constituent of Alzheimer's amyloid, Acta Neuropathol., 83, 260, 10.1007/BF00296787 · DOI · Paper page
  13. Christie, 1996, Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease, J. Neuropathol. Exp. Neurol., 55, 491, 10.1097/00005072-199604000-00012 · DOI · Paper page
  14. Citron, 1993, Excessive production of amyloid β-amyloid precursor protein gene, Proc. Natl. Acad. Sci. USA, 91, 11993, 10.1073/pnas.91.25.11993 · DOI · Paper page
  15. Clements, 1993, Effects of the mutation Glu2221, Neurosci. Lett., 161, 17, 10.1016/0304-3940(93)90129-9 · DOI
  16. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  17. Coria, 1988, Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis, Lab. Invest., 58, 454
  18. Cribbs, 1996, Widespread neuronal expression of thepresenilin-1, Am. J. Pathol., 148, 1797
  19. Cummings, 1993, Beta-amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease, Neurobiol. Aging, 14, 547, 10.1016/0197-4580(93)90038-D · DOI
  20. Curran, 1996, Permeability and residual plasma volume of human dutch variant and rat amyloid β-protein at the BBB, Soc. Neurosci. Abstr., 22, 1168
  21. Davies, 1988, A4 amyloid protein deposition and the diagnosis of Alzheime's disease: Prevalence in aged brains determined by immunohistochemistry compared with conventional neuropathological techniques, Neurology, 38, 1688, 10.1212/WNL.38.11.1688 · DOI
  22. Doan, 1996, Protein topology of presenilin 1, Neuron, 17, 1023, 10.1016/S0896-6273(00)80232-9 · DOI
  23. Duff, 1996, Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1, Nature, 383, 710, 10.1038/383710a0 · DOI
  24. Elder, 1996, Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains, J. Neurosci. Res., 45, 308, 10.1002/(SICI)1097-4547(19960801)45:3<308::AID-JNR13>3.0.CO;2-# · DOI
  25. Esch, 1990, Cleavage of amyloid β peptide during constitutive processing of its precursor, Science, 248, 1122, 10.1126/science.2111583 · DOI
  26. Evans, 1995, Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease, Proc. Natl. Acad. Sci. USA, 92, 763, 10.1073/pnas.92.3.763 · DOI · Paper page
  27. Friede, 1965, Enzyme histochemical studies of senile plaques, J. Neuropathol. Exp. Neurol., 24, 477, 10.1097/00005072-196507000-00008 · DOI
  28. Gallo, 1994, Potential role of apolipoprotein-E in fibrillogenesis, Am. J. Pathol., 145, 526
  29. Ghersi-Egea, 1996, Fate of cerebrospinal fluid-borne amyloid β-peptide: Rapid clearance into blood and appreciable accumulation by cerebral arteries, J. Neurochem., 67, 880, 10.1046/j.1471-4159.1996.67020880.x · DOI · Paper page
  30. Ghilardi, 1996, Intra-arterial infusion of1251–40, Neuroreport, 7, 2607, 10.1097/00001756-199611040-00040 · DOI · Paper page
  31. Giannakopoulos, 1997, Presenilin-1 immunoreactive neurons are preserved in late-onset Alzheimer's disease, Am. J. Pathol., 150, 429
  32. Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
  33. Golabek, 1996, The interaction between apolipoprotein E and Alzheimer's amyloid β-peptide is dependent on β-peptide conformation, J. Biol. Chem., 271, 10602, 10.1074/jbc.271.18.10602 · DOI
  34. Golde, 1990, Expression of β-amyloid protein precursor mRNAs; recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR, Neuron, 4, 253, 10.1016/0896-6273(90)90100-T · DOI
  35. Goldgaber, 1987, Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease, Science, 235, 877, 10.1126/science.3810169 · DOI
  36. Goodman, 1994, Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury, Exp. Neurol., 128, 1, 10.1006/exnr.1994.1107 · DOI
  37. Gowing, 1994, Chemical characterization of Aβ 17–42 peptide, a component of diffuse amyloid deposits of Alzheimer disease, J. Biol. Chem., 269, 10987, 10.1016/S0021-9258(19)78080-6 · DOI · Paper page
  38. Greenberg, 1996, Apolipoprotein E ϵ4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy, Stroke, 27, 1333, 10.1161/01.STR.27.8.1333 · DOI
  39. Guo, 1997, Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide, Neuroreport, 8, 379, 10.1097/00001756-199612200-00074 · DOI
  40. Hardy, 1996, New insights into the genetics of Alzheimer's disease, Ann. Med., 28, 255, 10.3109/07853899609033127 · DOI
  41. Harigaya, 1995, Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease, Biochem. Biophys. Res. Commun., 211, 1015, 10.1006/bbrc.1995.1912 · DOI
  42. Hilbich, 1991, Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease, J. Mol. Biol., 218, 149, 10.1016/0022-2836(91)90881-6 · DOI
  43. Hsiao, 1996, Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
  44. Irizarry, 1997, Aβ deposition is associated with neuropil change, but not overt neuronal loss in human amyloid precursor protein V717 F(PD APP) transgenic mice, J. Neurosci., 17, 7053, 10.1523/JNEUROSCI.17-18-07053.1997 · DOI · Paper page
  45. Jarrett, 1993, The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease, Biochemistry, 32, 4693, 10.1021/bi00069a001 · DOI · Paper page
  46. Joachim, 1988, Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging, Brain Res., 474, 100, 10.1016/0006-8993(88)90673-7 · DOI · Paper page
  47. Johnson-Wood, 1997, Amyloid precursor protein processing and Aβ42, Proc. Natl. Acad. Sci. USA, 94, 1550, 10.1073/pnas.94.4.1550 · DOI
  48. Kida, 1995, Early amyloid-β deposits show different immunoreactivity to the amino- and carboxyl-terminal regions of β-peptide in Alzheimer's disease and Down's syndrome brain, Neurosci. Lett., 193, 105, 10.1016/0304-3940(95)11678-P · DOI
  49. Kitaguchi, 1988, Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity, Nature, 331, 530, 10.1038/331530a0 · DOI
  50. Konig, 1992, Identification and differential expression of a novel alternative splice isoform of the β A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells, J. Biol. Chem., 267, 10804, 10.1016/S0021-9258(19)50090-4 · DOI
  51. Kosaka, 1997, The βAPP717 Alzheimer mutation increase the presentage of plasma amyloid-β protein ending at Aβ42(43), Neurology, 48, 741, 10.1212/WNL.48.3.741 · DOI
  52. Kosik, 1992, Is β-amyloid neurotoxic?, Neurobiol. Aging, 13, 535, 10.1016/0197-4580(92)90052-Y · DOI
  53. Koudinov, 1994, The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma, Biochem. Biophys. Res. Commun., 205, 1164, 10.1006/bbrc.1994.2788 · DOI
  54. Kovacs, 1996, Alzheimer associated presenilin 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells, Nature Med., 2, 224, 10.1038/nm0296-224 · DOI
  55. Kuo, 1996, Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains, J. Biol. Chem., 271, 4077, 10.1074/jbc.271.8.4077 · DOI · Paper page
  56. Kwok, 1997, Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype, Neuroreport, 10.1097/00001756-199704140-00043 · DOI
  57. L'Hernault, 1992, Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions, J. Cell Biol., 119, 55, 10.1083/jcb.119.1.55 · DOI
  58. LaDu, 1995, Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid, J. Biol. Chem., 270, 9039, 10.1074/jbc.270.16.9039 · DOI · Paper page
  59. Lah, 1997, Light and electron microscopic localization of presenilin-1 in primate brain, J. Neurosci., 17, 1971, 10.1523/JNEUROSCI.17-06-01971.1997 · DOI · Paper page
  60. Lalowski, 1996, The “non-amyloidogenic” p3 fragment (Aβ17–42) is a major constituent of Down syndrome cerebellar preamyloid, J. Biol. Chem., 271, 33623, 10.1074/jbc.271.52.33623 · DOI
  61. Lehmann, 1997, Evidence for a six-transmembrane domain structure of presenilin 1, J. Biol. Chem., 272, 12047, 10.1074/jbc.272.18.12047 · DOI
  62. Lemaire, 1989, The Pre A4695 precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons, Nucleic Acids Res., 17, 517, 10.1093/nar/17.2.517 · DOI
  63. Lendon, 1997, Exploring the etiology of Alzheimer disease using molecular genetics, J. Am. Med. Assoc., 277, 825, 10.1001/jama.1997.03540340059034 · DOI
  64. Levey, 1997, Presenilin-1 protein expression in familial and sporadic Alzheimer's disease, Ann. Neurol., 41, 742, 10.1002/ana.410410610 · DOI
  65. Levitan, 1996, Facilitation of lin-12-mediated sigalling by sel-12, aCaenorhabditis elegans, Nature, 377, 351, 10.1038/377351a0 · DOI
  66. Levy, 1990, Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, 248, 1124, 10.1126/science.2111584 · DOI
  67. Li, 1995, Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3, Proc. Natl. Acad. Sci. USA, 92, 12180, 10.1073/pnas.92.26.12180 · DOI
  68. Li, 1997, Alzheimer presenilins in the nuclearmembrane, interphase kinetochores, and centrosomes suggests a role in chromosome segragation, Cell, 90, 917, 10.1016/S0092-8674(00)80356-6 · DOI · Paper page
  69. Li, 1996, Membrane topology of the C. elegans SEL-12 presenilin, Neuron, 17, 1015, 10.1016/S0896-6273(00)80231-7 · DOI
  70. Lorenzo, 1994, Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red, Proc. Natl. Acad. Sci. USA, 91, 12243, 10.1073/pnas.91.25.12243 · DOI · Paper page
  71. Mahley, 1988, Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology, Science, 240, 622, 10.1126/science.3283935 · DOI · Paper page
  72. Maness, 1994, Passage of human amyloid beta-protein 1–40 across the murine blood–brain barrier, Life Sci., 55, 1643, 10.1016/0024-3205(94)00331-9 · DOI · Paper page
  73. Martel, 1996, Blood–brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs, Neurosci. Lett., 206, 157, 10.1016/S0304-3940(96)12462-9 · DOI · Paper page
  74. Masters, 1985, Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc. Natl. Acad. Sci. USA, 82, 4245, 10.1073/pnas.82.12.4245 · DOI · Paper page
  75. Matsubara, 1995, Characterization of apolipoprotein J-Alzheimer's A beta interaction, J. Biol. Chem., 270, 7563, 10.1074/jbc.270.13.7563 · DOI · Paper page
  76. McGeer, 1997, Apolipoprotein E4 (ApoE4) but not apoE3 or apoE2 potentiates β-amyloid protein activation of complement in vitro, Brain Res., 749, 135, 10.1016/S0006-8993(96)01324-8 · DOI
  77. McGeer, 1992, Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease, Neurology, 42, 447, 10.1212/WNL.42.2.447 · DOI
  78. Merken, 1996, Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing, FEBS Lett., 389, 297, 10.1016/0014-5793(96)00608-4 · DOI
  79. Miller, 1993, Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease, Arch. Biochem. Biophys., 301, 41, 10.1006/abbi.1993.1112 · DOI · Paper page
  80. Minor, 1996, Context-dependent secondary structure formation of a designed protein sequence, Nature, 380, 730, 10.1038/380730a0 · DOI
  81. Murphy, 1996, Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease, Am. J. Pathol., 149, 1839
  82. Namba, 1991, Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt–Jakob disease, Brain Res., 541, 163, 10.1016/0006-8993(91)91092-F · DOI · Paper page
  83. Naslund, 1995, Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain, Neuron, 15, 219, 10.1016/0896-6273(95)90079-9 · DOI
  84. Nathan, 1994, Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro, Science, 264, 850, 10.1126/science.8171342 · DOI · Paper page
  85. Nathan, 1995, The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization, J. Biol. Chem., 270, 19791, 10.1074/jbc.270.34.19791 · DOI · Paper page
  86. Pappolla, 1992, Immunohistochemical evidence of oxidative stress in Alzheimer's disease, Am. J. Pathol., 140, 621
  87. Pedro-Botet, 1992, Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism, Stroke, 23, 1556, 10.1161/01.STR.23.11.1556 · DOI
  88. Pike, 1993, Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state, J. Neurosci., 13, 1676, 10.1523/JNEUROSCI.13-04-01676.1993 · DOI · Paper page
  89. Podlisny, 1997, Presenilin proteins undergo heterogeneous endoproteolysis between Thr291299, Neurobiol. Dis., 3, 325, 10.1006/nbdi.1997.0129 · DOI
  90. Polvikoski, 1995, Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein, N. Eng. J. Med., 333, 1242, 10.1056/NEJM199511093331902 · DOI · Paper page
  91. Poirier, 1994, Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease, Trends Neurosci, 17, 525, 10.1016/0166-2236(94)90156-2 · DOI
  92. Prelli, 1988, Differences between vascular and plaque core amyloid in Alzheimer's disease, J. Neurochem., 51, 648, 10.1111/j.1471-4159.1988.tb01087.x · DOI
  93. Premkumar, 1996, Apolipoprotein E-ϵ4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease, Am. J. Pathol., 148, 2083
  94. Puttfarcken, 1997, Effect of apolipoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures, J. Neurochem., 68, 760, 10.1046/j.1471-4159.1997.68020760.x · DOI · Paper page
  95. Rebeck, 1993, Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions, Neuron, 11, 575, 10.1016/0896-6273(93)90070-8 · DOI · Paper page
  96. Robakis, 1987, Molecular cloning and characterization of a cDNA encoding the neuritic plaque amyloid peptides, Proc. Natl. Acad. Sci. USA, 84, 4190, 10.1073/pnas.84.12.4190 · DOI
  97. Roher, 1993, β-Amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 10836, 10.1073/pnas.90.22.10836 · DOI · Paper page
  98. Saito, 1995, Vector-mediated delivery of1251–401–40, Proc. Natl. Acad. Sci. USA, 92, 10227, 10.1073/pnas.92.22.10227 · DOI · Paper page
  99. Sanan, 1994, Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3, J. Clin. Invest., 94, 860, 10.1172/JCI117407 · DOI · Paper page
  100. Schellenberg, 1992, Genetic linkage for a novel familial Alzheimer's disease locus on chromosome 14, Science, 258, 868, 10.1126/science.1411576 · DOI
  101. Schmechel, 1993, Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 9649, 10.1073/pnas.90.20.9649 · DOI · Paper page
  102. Schwarzman, 1994, Transthyretin sequesters amyloid beta protein and prevents amyloid formation, Proc. Natl. Acad. Sci. USA, 91, 8368, 10.1073/pnas.91.18.8368 · DOI
  103. Seubert, 1997, ApoE genotype influences the CSF level of Aβ42 in Alzheimer's disease, Neurology, 48, A379
  104. Sheng, 1996, Apolipoprotein E distribution among diffuse plaque types in Alzheimer's disease: Implications for its role in plaque progression, Neuropathol. Appl. Neurobiol., 22, 334, 10.1111/j.1365-2990.1996.tb01112.x · DOI
  105. Shimano, 1989, Plasma apolipoproteins in patients with multi-infarct dementia, Atherosclerosis, 79, 257, 10.1016/0021-9150(89)90132-9 · DOI
  106. Simmons, 1994, Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol., 45, 373, 10.1016/S0026-895X(25)10007-2 · DOI
  107. Sisodia, 1990, Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing, Science, 248, 492, 10.1126/science.1691865 · DOI
  108. Slooter, 1997, Apolipoprotein E ϵ4 and the risk of dementia with stroke, J. Am. Med. Assoc., 277, 818, 10.1001/jama.1997.03540340052032 · DOI
  109. Smith, 1994, Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease, Am. J. Pathol., 145, 42
  110. Snow, 1987, Sulphated glycosaminoglycans: a common constituent of all amyloid?, Lab. Invest., 56, 120
  111. Soto, 1996, Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation, Biochem. Biophys. Res. Commun., 226, 672, 10.1006/bbrc.1996.1413 · DOI
  112. Strittmatter, 1993, Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
  113. Suzuki, 1994, An increase percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β PP717) mutants, Science, 264, 1336, 10.1126/science.8191290 · DOI · Paper page
  114. Tabaton, 1994, Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid, Biochem. Biophys. Res. Commun., 200, 1598, 10.1006/bbrc.1994.1634 · DOI
  115. Tabaton, 1996, Type and amount of the apolipoprotein E/amyloid β protein complex in Alzheimer's and control brain, Soc. Neurosci. Abstr., 22, 1696
  116. Tagliavini, 1988, Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals, Neurosci. Lett., 93, 191, 10.1016/0304-3940(88)90080-8 · DOI
  117. Tamaoka, 1994, Biochemical evidence for the long-tail form (Aβ1–42/43, Biochem. Biophys. Res. Commun., 205, 834, 10.1006/bbrc.1994.2740 · DOI
  118. Tanzi, 1988, Protease inhibitor domain encoded by an amyloid precursor mRNA associated with Alzheimer's disease, Nature, 331, 528, 10.1038/331528a0 · DOI
  119. Tanzi, 1996, The gene defects responsible for familial Alzheimer's disease, Neurobiol. Dis., 3, 159, 10.1006/nbdi.1996.0016 · DOI · Paper page
  120. Teller, 1996, Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome, Nature Med., 2, 93, 10.1038/nm0196-93 · DOI
  121. Thinakaran, 1996, Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo, Neuron, 17, 181, 10.1016/S0896-6273(00)80291-3 · DOI
  122. Timmers, 1990, Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis Dutch type, Neurosci. Lett., 118, 223, 10.1016/0304-3940(90)90632-J · DOI
  123. Uchihara, 1996, Widespread immunoreactivity of presenilin in neurons of normal and Alzheimer's disease brains: Double-labeling immunohistochemical study, Acta Neuropathol., 92, 325, 10.1007/s004010050526 · DOI
  124. Ueda, 1993, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 11282, 10.1073/pnas.90.23.11282 · DOI
  125. Ueda, 1994, Amyloid beta protein-induces neuronal cell death: Neurotoxic properties of aggregated amyloid beta protein, Brain Res., 639, 240, 10.1016/0006-8993(94)91736-1 · DOI
  126. van Nostrand, 1990, Protease nexin-II (amyloid β-protein precursor): A platelet alpha granule protein, Science, 248, 745, 10.1126/science.2110384 · DOI
  127. Vigo-Pelfrey, 1993, Characterization of beta-amyloid peptide from human cerebrospinal fluid, J. Neurochem., 61, 1965, 10.1111/j.1471-4159.1993.tb09841.x · DOI · Paper page
  128. Vito, 1996, Interfering with apoptosis: Ca2+ALG-3, Science, 271, 521, 10.1126/science.271.5248.521 · DOI
  129. Wang, 1991, Secretion of the β/A4 amyloid precursor protein, J. Biol. Chem., 266, 16960, 10.1016/S0021-9258(18)55397-7 · DOI
  130. Weber, 1997, Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques, Exp. Neurol., 143, 37, 10.1006/exnr.1996.6348 · DOI
  131. Weidemann, 1997, Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein, Nature Med., 3, 328, 10.1038/nm0397-328 · DOI
  132. Wisniewski, 1989, Spectrum of morphological appearance of amyloid deposits in AD, Acta Neuropathol., 78, 337, 10.1007/BF00688170 · DOI
  133. Wisniewski, 1994, Age-associated development of diffuse and thioflavine-S-positive plaques in Down syndrome, Dev. Brain Dysfunct., 7, 330
  134. Wisniewski, 1996, Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines, Neuropathol. Appl. Neurobiol., 22, 3, 10.1111/j.1365-2990.1996.tb00839.x · DOI
  135. Wisniewski, 1991, Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation, Biochem. Biophys. Res. Commun., 179, 1247, 10.1016/0006-291X(91)91706-I · DOI
  136. Wisniewski, 1994, Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro, Am. J. Pathol., 145, 1030
  137. Wisniewski, 1994, The amino acid sequence of neuritic plaque amyloid from a familial Alzheimer's disease patient, Ann. Neurol., 35, 245, 10.1002/ana.410350223 · DOI
  138. Wisniewski, 1995, Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis, Am. J. Pathol., 147, 238
  139. Wisniewski, 1995, S182 protein in Alzheimer's disease neuritic plaques, Lancet, 346, 1366, 10.1016/S0140-6736(95)92379-9 · DOI
  140. Wisniewski, 1996, HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions, Neuroreport, 7, 667, 10.1097/00001756-199601310-00068 · DOI
  141. Wisniewski, 1996, Amyloid β 1–42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs, Biochem. J., 313, 575, 10.1042/bj3130575 · DOI
  142. Wisniewski, 1997, Presenilin is associated with Alzheimer's disease amyloid, Am. J. Pathol., 151, 601
  143. Wisniewski, 1992, Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosci. Lett., 135, 235, 10.1016/0304-3940(92)90444-C · DOI · Paper page
  144. Wisniewski, 1996, Molecular biology of brain aging and neurodegenerative disorders, Acta Neurobiol. Exp., 56, 267, 10.55782/ane-1996-1132 · DOI
  145. Wolozin, 1996, Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation, Science, 274, 1710, 10.1126/science.274.5293.1710 · DOI
  146. Wong, 1997, Massive brain hemorrhage, abnormal skeletal development and lethality in presenilin 1 deficient embryos, Mol. Mech. Alzheimer's Dis., 14
  147. Yamaguchi, 1988, Diffuse type of senile plaques in the brains of Alzheimer-type dementia, Acta Neuropathol., 77, 113, 10.1007/BF00687420 · DOI · Paper page
  148. Yamaguchi, 1991, Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: Comparison with primitive plaques, Acta Neuropathol., 82, 13, 10.1007/BF00310918 · DOI
  149. Yamazaki, 1991, Ultrastructural localization of argyrophilic substances in diffuse plaques of Alzheimer-type dementia demonstrated by methenamine silver staining, Acta Neuropathol., 81, 540, 10.1007/BF00310135 · DOI
  150. Yang, 1997, Characterization of the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma, J. Neurochem., 68, 721, 10.1046/j.1471-4159.1997.68020721.x · DOI · Paper page
  151. Younkin, 1995, Evidence that Aβ 42 is the real culprit in Alzheimer's disease, Ann. Neurol., 37, 287, 10.1002/ana.410370303 · DOI
  152. Zlokovic, 1993, Blood–brain barrier transport of circulating Alzheimer's amyloid beta, Biochem. Biophys. Res. Commun., 197, 1034, 10.1006/bbrc.1993.2582 · DOI · Paper page
  153. Zlokovic, 1994, Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta, Biochem. Biophys. Res. Commun., 205, 1431, 10.1006/bbrc.1994.2825 · DOI
  154. Zlokovic, 1996, Cerebrovascular transport of Alzheimer's amyloid β and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood–brain barrier, Life Sci., 59, 1483, 10.1016/0024-3205(96)00310-4 · DOI
  155. Zlokovic, 1996, Glycoprotein 330/megalin: Probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid β at the blood–brain and blood–cerebrospinal fluid barriers, Proc. Natl. Acad. Sci. USA, 93, 4229, 10.1073/pnas.93.9.4229 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Wisniewski, T., Ghiso, J., & Frangione, B.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
1997
Volume
4
Issue
5
Pages
313-328
ISSN
0969-9961
DOI
10.1006/nbdi.1997.0147
Cited by
134
References
30
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review